Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aequus Pharmaceuticals Inc (TSE:AQS)
:AQS
Holding TSE:AQS?
Track your performance easily
AQS Stock Chart & Stats
Day’s Range― - ―
52-Week Range<C$0.01 - C$0.04
Previous CloseN/A
Volume10.00K
Average Volume (3M)41.03K
Market Cap
C$1.06M
Enterprise ValueC$8.19M
Total Cash (Recent Filing)$473.24K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.44
Next Earnings
Apr 30, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding132,634,430
10 Day Avg. Volume108,850
30 Day Avg. Volume41,027
Standard Deviation0.24
R-Squared0.00003
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.61
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market Cap7.72
Enterprise Value/Revenue19.83
Enterprise Value/Gross Profit57.03
Enterprise Value/Ebitda-3.35
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Aequus Pharmaceuticals News
PremiumCompany Announcements
Aequus Pharmaceuticals Reports Revenue Growth Amid Restructuring
PremiumCompany Announcements
Aequus Pharmaceuticals Reports Strong Q2 Financials
PremiumCompany Announcements
Aequus Pharmaceuticals Celebrates Zimed® PF Sales Record
PremiumCompany Announcements
Aequus to Distribute Innovative Glaucoma Device
PremiumCompany Announcements
Aequus Reports Q1 Financials and ZIMED® PF Launch
PremiumCompany Announcements
Aequus Boosts Supply Amid Bimatoprost ShortageAQS FAQ
What was Aequus Pharmaceuticals Inc’s price range in the past 12 months?
Aequus Pharmaceuticals Inc lowest stock price was <C$0.01 and its highest was C$0.04 in the past 12 months.
What is Aequus Pharmaceuticals Inc’s market cap?
Aequus Pharmaceuticals Inc’s market cap is C$1.06M.
When is Aequus Pharmaceuticals Inc’s upcoming earnings report date?
Aequus Pharmaceuticals Inc’s upcoming earnings report date is Apr 30, 2025 which is in 101 days.
How were Aequus Pharmaceuticals Inc’s earnings last quarter?
Aequus Pharmaceuticals Inc released its earnings results on Nov 09, 2024. The company reported -C$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.005.
Is Aequus Pharmaceuticals Inc overvalued?
According to Wall Street analysts Aequus Pharmaceuticals Inc’s price is currently Overvalued.
Does Aequus Pharmaceuticals Inc pay dividends?
Aequus Pharmaceuticals Inc does not currently pay dividends.
What is Aequus Pharmaceuticals Inc’s EPS estimate?
Aequus Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aequus Pharmaceuticals Inc have?
Aequus Pharmaceuticals Inc has 132,634,430 shares outstanding.
What happened to Aequus Pharmaceuticals Inc’s price movement after its last earnings report?
Aequus Pharmaceuticals Inc reported an EPS of -C$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Aequus Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in TSE:AQS
---
Company Description
Aequus Pharmaceuticals Inc
Aequus Pharmaceuticals Inc is a Canada based specialty pharmaceutical company. The firm's operating segments are Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. Aequus is developing a pipeline of products in neurology and psychiatry. The company's launched and pipeline products are Tacrolimus IR, Vistitan, AQS1304, AQS1303, and others.
---
Technical Analysis
Revive Therapeutics
―
BioMark Diagnostics
―
Medexus Pharmaceuticals Inc
―
Luff Enterprises
―
Target Group
―
---